Why the study?
Do pharmacist-clinician collaborative visits within 7 days after hospital discharge reduce the risk of 30-day hospital readmission compared to visits eight or more days after discharge in adult primary care patients on high-risk medications?
Population
Adult primary care patients taking at least 1 high-risk medication and at least 10 total medications
Design
Retrospective cohort study
Follow-up
180 days
Authors
Loading...
Supports flexible post-discharge scheduling; leaves open optimal timing pending randomized trials.
Do pharmacist-clinician collaborative visits within 7 days after hospital discharge reduce the risk of 30-day hospital readmission compared to visits eight or more days after discharge in adult primary care patients on high-risk medications?
Pharmacist-clinician collaborative visits can be flexibly scheduled beyond 7 days post-discharge without significantly increasing the risk of 30-day hospital readmission.
Herges et al. (2018) studied this question.